CN107773600A - A kind of preparation method of acne compound - Google Patents

A kind of preparation method of acne compound Download PDF

Info

Publication number
CN107773600A
CN107773600A CN201610744384.7A CN201610744384A CN107773600A CN 107773600 A CN107773600 A CN 107773600A CN 201610744384 A CN201610744384 A CN 201610744384A CN 107773600 A CN107773600 A CN 107773600A
Authority
CN
China
Prior art keywords
acne
preparation
parts
acne compound
filtrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610744384.7A
Other languages
Chinese (zh)
Inventor
贺改英
翟春涛
李成亮
沈丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laibo Cosmeceutical Technology (shanghai) Ltd By Share Ltd
Original Assignee
Laibo Cosmeceutical Technology (shanghai) Ltd By Share Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laibo Cosmeceutical Technology (shanghai) Ltd By Share Ltd filed Critical Laibo Cosmeceutical Technology (shanghai) Ltd By Share Ltd
Priority to CN201610744384.7A priority Critical patent/CN107773600A/en
Publication of CN107773600A publication Critical patent/CN107773600A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/748Oldenlandia or Hedyotis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/483Gleditsia (locust)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of preparation method of acne compound, belong to cosmetic skin field.It is as follows that it mixes Chinese medicinal component:15 40 parts of oldenlandia diffusa, 20 45 parts of caulis lonicerae, 20 40 parts of red sage root, 15 45 parts of fruitlet Chinese honey locust seed, it is extracted by alcohol reflux, filtering and impurity removing, the methods of being concentrated under reduced pressure and purifying prepare anti-acne compound.A kind of preparation method of acne compound provided by the invention, the method solvent can reclaim, do not produce waste water, cost is low, the active component of medicinal material is not damaged, product active ingredient that the method obtains is high, stably, safely, it is possible to reduce the formation of acne print and prevents the generation of acne after acne and acne, the defects of overcoming existing naturally bad, poor heat resistance of product for resolving poxes stability etc. in the market.

Description

A kind of preparation method of acne compound
Technical field
The present invention relates to cosmetic skin field, specifically a kind of preparation method of acne compound.
Background technology
Acne is a kind of chronic inflammation disease of puberty common pilosebaceous follicle, is a kind of common skin of clinic Disease, be apt to occur in face, shirtfront and the back of puberty men and women, the principal pathogenetic age between 13-29 year, next to that in 20-29 Between year, acne lesions feature is mainly characterized by papule, warts, tubercle, tumour and a variety of infringements of scar.The patient of acne, Particularly patient's Confidence of Medium or severe type is reduced, and quality of life reduces, and is presented with the table in terms of depressed and other abalienations Existing, wherein in acne crowd, the scar that acne is formed accounts for teen-age 20%.
Due to the pollution of environment and the increase of life stress, the incidence of disease of China's whelk is in ascendant trend year by year, and 80% More than people it is different degrees of encountered whelk problem, so anti-acne has the very big market demand.
Pathogenesis of acne complicated mechanism, mainly with androgen secretion, hair follicle conduit mouth hyperkeratinization, propionibacterium acnes it is big Amount breeding and inflammation etc. are relevant.Secondly, as the factors such as inherent cause, some foods, medicine, cosmetics can influence, induce and Aggravate the generation of acne.
At present to the treatment of acne, doctor suggests by based on oral tretinoin medicines and antibiotics, the course for the treatment of compared with Long, side effect is larger, and curative effect is indefinite, so in the market urgent need safety, stabilization
Effectively, the anti-acne skin care item without any hormone, antibiotic.
The content of the invention
The invention aims to provide a kind of preparation method of acne compound, the method solvent can be reclaimed, do not produced Raw waste water, cost is low, does not damage the active component of medicinal material, and the product active ingredient that the method obtains is high, stably, safely, can be with The formation of acne print and the generation of prevention acne, overcome existing natural product for resolving poxes in the market after reduction acne and acne The defects of stability is bad, poor heat resistance etc..
A kind of preparation method of acne compound of the present invention, comprises the following steps:
(1) the mixing medicinal material of oldenlandia diffusa, caulis lonicerae, red sage root and fruitlet Chinese honey locust seed is weighed, adds mixing medicinal material matter The ethanol solution of 10-20 times of amount, 3h is extracted at 70-80 DEG C, is then filtered, filters out liquid;
(2) filtrate after step (1) is filtered adds flocculant, stirs to flocculate and continues to stir 20min after occurring, quiet Filtered after putting 30min;
(3) filtrate after step (2) is filtered concentrates 1-5 hours at 40-70 DEG C, and filtrate adds water to gross mass and is after concentration 0.3-0.8 times of mixing quality of medicinal material;
(4) solvent is added, medicinal herb componentses are redissolved;
(5) filtrate is purified;
(6) sterilize, detection.
At least one of flocculant is in the step (2) lignin and chitosan.
The mass fraction of flocculant is 1-10% (w/w), mixing speed 30-100r/min in the step (2).
Pressure when being concentrated in the step (3) is 0.01-0.05Mpa, and the alcohol vapour being evaporated is after condensation Recovery, return to step (1) use.
Solvent is at least one of butanediol, propane diols, glycerine, DPG in the step (4).
Purifying is realized by way of ultrafiltration in the step (5), the small active ingredient of purifying molecule amount.
The mass fraction of a component is oldenlandia diffusa in the mixing medicinal material:Caulis lonicerae:Red sage root:Fruitlet Chinese honey locust seed =15-40 parts:20-45 parts:20-40 parts:15-45 parts.
It is of the invention to be had the following advantages compared with existing product for resolving poxes:
(1) the product for resolving poxes active ingredient that the present invention extracts is high, and good penetrability, impurity is few, is used alone just with notable Anti-acne and reduce acne print the effect of, reached unlike many product for resolving poxes effects are weaker on the market, it is necessary to compound other product for resolving poxes To acne-removing.
(2) solvent used in extraction process of the present invention can reclaim, and recycle, do not produce waste water.
(3) product for resolving poxes of the invention is directed to multiple target spots caused by acne, has suppression well to propionibacterium acnes Make use, and suppress 5 alpha-reductases activity, reduce due to fat secretion excessively caused by acne.
(4) no matter equal under low temperature or hot conditions product for resolving poxes of the invention be in formula application aspect, easily addition It can add, and stability is good, phenomena such as being not in discoloration and be layered.
Embodiment
Below in conjunction with specific example, present invention is described and explanation, in order to which the public is better understood from this The technology contents of invention, rather than the limitation to the technology contents, under identical or approximate principle, to the processing step The improvement of progress, including reaction condition, agents useful for same are improved and replaced, and reach identical purpose, then all in the present patent application institute Within claimed technical scheme.
The preferred embodiments of the present invention are illustrated below, it will be appreciated that preferred embodiment described herein is only used In the description and interpretation present invention, it is not intended to limit the present invention.
Embodiment 1
(1) the mixing medicine of 20 parts of 40 parts of oldenlandia diffusa, 20 parts of caulis lonicerae, 20 parts of red sage root and fruitlet Chinese honey locust seed is weighed Material, the ethanol solution of 10 times of quality of medicinal material of mixing is added, 3h is extracted at 70 DEG C, filtered, filter out liquid.
(2) filtrate after step (1) is filtered adds flocculant, stirs to flocculate and continues to stir 20min after occurring, quiet Filtered after putting 30min.
(3) filtrate after step (2) is filtered concentrates 2.5 hours at 60 DEG C, and it is 0.4 times that dense filtrate, which adds water to gross mass, Mix quality of medicinal material.
(4) solvent is added, medicinal herb componentses are redissolved;
(5) filtrate is purified by milipore filter;
(6) sterilize, detection.
The lignin that flocculant is in the step (2).
The mass fraction of flocculant is 5% (w/w), mixing speed 80r/min in the step (2).
Pressure when being concentrated in the step (3) is 0.02Mpa, and the alcohol vapour being evaporated reclaims after condensation, Return to step (1) uses.
Solvent is butanediol in the step (4).
Purifying is realized by way of ultrafiltration in the step (5), the small active ingredient of purifying molecule amount.
Embodiment 2
(1) the mixing medicine of 20 parts of 20 parts of oldenlandia diffusa, 40 parts of caulis lonicerae, 20 parts of red sage root and fruitlet Chinese honey locust seed is weighed Material, 15 times of ethanol solutions are added, 3h is extracted at 76 DEG C, filtered, filter out liquid.
(2) filtrate after step (1) is filtered adds flocculant, stirs to flocculate and continues to stir 20min after occurring, quiet Filtered after putting 30min.
(3) for the filtrate after step (2) is filtered in 60 DEG C of concentrations, dense filtrate adds water to the mixing medicine that gross mass is 0.5 times Material amount.
(4) solvent is added, medicinal herb componentses are redissolved.
(5) filtrate is purified by milipore filter;
(6) sterilize, detection.
Flocculant is chitosan in the step (2).
The mass fraction of flocculant is 6% (w/w), mixing speed 90r/min in the step (2).
Pressure when being concentrated in the step (3) is 0.04Mpa, and the alcohol vapour being evaporated reclaims after condensation, Return to step (1) uses.
Solvent is propane diols in the step (4).
Purifying is realized by way of ultrafiltration in the step (5), the small active ingredient of purifying molecule amount.
Embodiment 3
(1) the mixing medicine of 20 parts of 20 parts of oldenlandia diffusa, 20 parts of caulis lonicerae, 40 parts of red sage root and fruitlet Chinese honey locust seed is weighed Material, 15 times of ethanol solutions are added, 3h is extracted at 80 DEG C, filtered, filter out liquid.
(2) filtrate after step (1) is filtered adds flocculant, stirs to flocculate and continues to stir 20min after occurring, quiet Filtered after putting 30min.
(3) for the filtrate after step (2) is filtered in 60 DEG C of concentrations, dense filtrate adds water to the mixing medicine that gross mass is 0.4 times Material amount.
(4) solvent is added, medicinal herb componentses are redissolved.
(5) filtrate is purified by milipore filter;
(6) sterilize, detection.
The lignin that flocculant is in the step (2).
The mass fraction of flocculant is 5% (w/w), mixing speed 80r/min in the step (2).
Pressure when being concentrated in the step (3) is 0.04Mpa, and the alcohol vapour being evaporated reclaims after condensation, Return to step (1) uses.
Solvent is DPG in the step (4).
Purifying is realized by way of ultrafiltration in the step (5), the small active ingredient of purifying molecule amount.
Effect example
(1) minimum inhibitory concentration of the observation to propionibacterium acnes
1) embodiment anti-acne compound is diluted to propane diols 5% to 0.5% solubility, 0.5% is differed between concentration Concentration.
2) test strain and culture medium:Propionibacterium acnes (ATCC6919).Propionibacterium acnes culture medium, regulation pH are 6.6~7.0.Agar 15g/L, 115 DEG C of 20min autoclavings are added wherein in solid medium.
3) measure of minimum inhibitory concentration (MIC value):The μ of decoction 100 of the μ L of bacterium solution 100 and various concentrations is added in micropore L, at the same set be not added with bacterium negative control and be not added with decoction normal growth control, every kind of medicine do 3 it is parallel, average.Put 37 DEG C of anaerobism are incubated, and result is observed after 48h.Using muddiness is visually determined whether, data are read using direct method.As a result judge On condition that growth control is good, blank control asepsis growth is clear, other holes with drug concentration gradient raise and the growth of bacterium by To suppression.
4) experimental result
The minimum inhibitory concentration (MIC value) of different embodiments
Embodiment Minimum inhibitory concentration (MIC value)
Embodiment 1 1.5%
Embodiment 2 2.0%
Embodiment 3 2.0%
(2) the suppression effect of observation to 5α-reductase
1) embodiment anti-acne compound is diluted to propane diols 5% solubility.
2) when 5α-reductase catalysis testosterone (T) is converted into protona (DHT) reduced Coenzyme II (NADPH) is relied on to make For hydrogen donor, NADPH has intense fluorescence in itself, after NADPH and reductase and substrate reactions, NADPH generation NADP+, and fluorescence It is quenched therewith, therefore the activity of 5α-reductase can be investigated by fluorescence detector measure NADPH fluorescence intensity.
The orifice plate of black 96 is taken, adds the μ l of testosterone 5 (20 μm of ol/L), the μ l of enzyme extract 5, the μ l (1.3mM) of Finasteride 5 or time The μ l of compound 20 (50 μM of final concentration) are selected, buffer solution (sucrose 0.73mol/L, calcium chloride 1.91mmol/L) is to 195 μ l, at 37 DEG C Lower reaction 30min, the μ l (20mmol/L) of NADPH 5 are added, 1h is reacted at 37 DEG C, absorb light 340nm, transmitting light 495nm is surveyed Determine fluorescence intensity.If the reaction tube for being not added with enzyme extract is blank control, if only enzyme-added extract but being not added with Finasteride and change The reaction tube of compound is compareed for 100% enzymatic activity, and the percent inhibition of medicine is calculated by following equation:
Inhibiting rate=(blank tube average fluorescent strength-chemical combination property management average fluorescent strength)/(blank tube mean fluorecence is strong Spend -100% enzymatic activity control fluorescence intensity) × 100
3) experimental result
Suppression effect to 5α-reductase of different embodiments
Embodiment Inhibiting rate
Embodiment 1 42.5%
Embodiment 2 46.5%
Embodiment 3 40.8%
Finally illustrate, the above embodiments are merely illustrative of the technical solutions of the present invention and it is unrestricted, although with reference to compared with The present invention is described in detail good embodiment, it will be understood by those of skill in the art that can be to the technical side of the present invention Case is modified or equivalent substitution, and without departing from the objective and scope of technical solution of the present invention, it all should cover in the present invention Right.

Claims (7)

1. a kind of preparation method of acne compound, it is characterised in that comprise the following steps:
(1) the mixing medicinal material of oldenlandia diffusa, caulis lonicerae, red sage root and fruitlet Chinese honey locust seed is weighed, adds mixing quality of medicinal material 10- 20 times of ethanol solution, 3h is extracted at 70-80 DEG C, is then filtered, filters out liquid;
(2) filtrate after step (1) is filtered adds flocculant, stirs to flocculate and continues to stir 20min after occurring, stands Filtered after 30min;
(3) filtrate after step (2) is filtered concentrates 1-5 hours at 40-70 DEG C, and it is 0.3- that filtrate, which adds water to gross mass, after concentration 0.8 times of mixing quality of medicinal material;
(4) solvent is added, medicinal herb componentses are redissolved;
(5) filtrate is purified;
(6) sterilize, detection.
2. the preparation method of a kind of acne compound according to claim 1, it is characterised in that flocculated in the step (2) At least one of lignin and chitosan that agent is.
3. the preparation method of a kind of acne compound according to claim 1, it is characterised in that flocculated in the step (2) The mass fraction of agent is 1-10% (w/w), mixing speed 30-100r/min.
4. the preparation method of a kind of acne compound according to claim 1, it is characterised in that concentrated in the step (3) When pressure be 0.01-0.05Mpa, the alcohol vapour being evaporated reclaims after condensation, return to step (1) use.
A kind of 5. preparation method of acne compound according to claim 1, it is characterised in that solvent in the step (4) It is at least one of butanediol, propane diols, glycerine, DPG.
6. the preparation method of a kind of acne compound according to claim 1, it is characterised in that purified in the step (5) It is to be realized by way of ultrafiltration, the small active ingredient of purifying molecule amount.
A kind of 7. preparation method of acne compound according to claim 1, it is characterised in that each group in the mixing medicinal material The mass fraction divided is oldenlandia diffusa:Caulis lonicerae:Red sage root:Fruitlet Chinese honey locust seed=15-40 parts:20-45 parts:20-40 parts: 15-45 parts.
CN201610744384.7A 2016-08-26 2016-08-26 A kind of preparation method of acne compound Pending CN107773600A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610744384.7A CN107773600A (en) 2016-08-26 2016-08-26 A kind of preparation method of acne compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610744384.7A CN107773600A (en) 2016-08-26 2016-08-26 A kind of preparation method of acne compound

Publications (1)

Publication Number Publication Date
CN107773600A true CN107773600A (en) 2018-03-09

Family

ID=61441040

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610744384.7A Pending CN107773600A (en) 2016-08-26 2016-08-26 A kind of preparation method of acne compound

Country Status (1)

Country Link
CN (1) CN107773600A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108969429A (en) * 2018-10-16 2018-12-11 广州科玛生物科技股份有限公司 A kind of anti-acne essence
CN109157450A (en) * 2018-10-16 2019-01-08 广州科玛生物科技股份有限公司 A kind of anti-acne essence cream
CN109157451A (en) * 2018-10-16 2019-01-08 广州科玛生物科技股份有限公司 A kind of anti-acne mildy wash
CN109260075A (en) * 2018-10-16 2019-01-25 广州科玛生物科技股份有限公司 A kind of anti-acne opsonic water

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103393801A (en) * 2013-07-31 2013-11-20 广州市娇兰化妆品有限公司 Traditional Chinese medicine composite extract with effect of removing acnes, and preparation method and application thereof
CN105168478A (en) * 2015-08-28 2015-12-23 无限极(中国)有限公司 Skin care product and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103393801A (en) * 2013-07-31 2013-11-20 广州市娇兰化妆品有限公司 Traditional Chinese medicine composite extract with effect of removing acnes, and preparation method and application thereof
CN105168478A (en) * 2015-08-28 2015-12-23 无限极(中国)有限公司 Skin care product and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李全林: "《现代生物工程》", 31 December 2008, 东南大学出版社 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108969429A (en) * 2018-10-16 2018-12-11 广州科玛生物科技股份有限公司 A kind of anti-acne essence
CN109157450A (en) * 2018-10-16 2019-01-08 广州科玛生物科技股份有限公司 A kind of anti-acne essence cream
CN109157451A (en) * 2018-10-16 2019-01-08 广州科玛生物科技股份有限公司 A kind of anti-acne mildy wash
CN109260075A (en) * 2018-10-16 2019-01-25 广州科玛生物科技股份有限公司 A kind of anti-acne opsonic water
CN109157450B (en) * 2018-10-16 2021-06-15 广州科玛生物科技股份有限公司 Acne-removing essence
CN108969429B (en) * 2018-10-16 2021-06-15 广州科玛生物科技股份有限公司 Acne removing essence
CN109260075B (en) * 2018-10-16 2021-06-15 广州科玛生物科技股份有限公司 Acne-removing conditioning water
CN109157451B (en) * 2018-10-16 2021-06-15 广州科玛生物科技股份有限公司 Acne-removing facial cleanser

Similar Documents

Publication Publication Date Title
CN107773600A (en) A kind of preparation method of acne compound
CN110090190B (en) Soothing cooling liquid for baby plants and preparation method thereof
CN101336874A (en) Water-solubility active extract in fruit skin, preparation method and use thereof
CN112704712B (en) Traditional Chinese medicine composition for eye care and preparation method and application thereof
CN108042433B (en) Whitening antioxidant plant composition, plant composition fermentation liquor, preparation method and application
CN110236981B (en) Whitening plant polysaccharide composition and application thereof
KR101975951B1 (en) Manufacturing Method of Japanese Rose Flower Extract and Rose Flower Extract for Whitening Cosmetic Preparations containing these Extracts
CN103992416A (en) Isaria cosmopaltriae yasuda polysaccharide and applications thereof in preparing nerve-protective and anti-aging drug
CN110101597A (en) It is a kind of for skin-whitening and the composition of skin barrier damaging action to be repaired
CN107080722A (en) A kind of Whelk-eliminating paste
CN105039101A (en) Propolis wine preparing technology
CN108014023A (en) A kind of Pimple removing scream of the powder containing Khotan jade
CN107737061A (en) A kind of cosmetic composition and preparation method thereof
CN112603868B (en) Application of gentian root extract, composition containing gentian root extract, cosmetics and preparation method of cosmetics
CN102321144A (en) Method for extracting ursolic acid from red jujube
CN107582691A (en) Compound phellodendron bark liquid paint is gargled gel
EP3756664A1 (en) Osteoclast differentiation inhibitor containing urolithin
CN101579115A (en) Nano selenium tea noni health food and production method thereof
CN105213254B (en) Preparation method and application of compound miracle fruit leaf extract
CN114191358B (en) Plant composition with whitening effect and application of plant composition in cosmetics
CN103800386B (en) A kind of Cordyceps cicadae Shing extract and preparing the application in neuroprotective and antiaging agent
CN115487131A (en) Daily facial skin care composition and preparation method thereof
WO2021082889A1 (en) Environmentally-friendly method of preparing composition containing anti-inflammatory active ingredient and application thereof
CN103565960B (en) A kind of semi-bionic extraction technology prepares the method for Semen Hoveniae extract (Fructus Hoveniae extract)
CN104523825B (en) Spearmint essential oil is preparing the application in treating allergic skin medicine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180309